ABBOTT LABORATORIES holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 11,385,577 | $1,510,296,828 | 4.74% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 12, 2025 |
| June 30, 2025 | 10,669,498 | $1,451,158,449 | 4.45% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 13, 2025 |
| Sept. 30, 2025 | 7,420,604 | $993,915,673 | 3.23% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 3,962,230 | $496,427,772 | 2.12% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 15,081 | $1,548,326 | 0.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2026 |
| June 30, 2026 | 3,156 | $286,379 | 0.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 4, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.